Coronavirus | Panacea Biotec shares zoom 20% on collaboration with U.S.-based Refana to develop vaccine

llowing the announcement, shares of Panacea Biotec advanced 20% to ₹202.80 — its upper circuit limit — on the BSE

from The Hindu - Business https://ift.tt/30uPUxY
via IFTTT

Post a Comment

0 Comments